Mean Oral Cavity Organ-at-Risk Dose Predicts Opioid Use and Hospitalization during Radiotherapy for Patients with Head and Neck Tumors

Mean Oral Cavity Organ-at-Risk Dose Predicts Opioid Use and Hospitalization during Radiotherapy for Patients with Head and Neck Tumors

Background: Approximately 75% of all head and neck cancer patients are treated with radiotherapy (RT). RT to the oral cavity results in acute and late adverse events which can be severe and detrimental to a patient’s quality of life and function. The purpose of this study was to explore associations...

Full description

Bibliographic Details
Main Authors: Robert L. Foote, W. Scott Harmsen, Adam C. Amundson, Alan B. Carr, Mauricio E. Gamez, Yolanda I. Garces, Scott C. Lester, Daniel J. Ma, Lisa A. McGee, Eric J. Moore, Michelle A. Neben Wittich, Samir H. Patel, David M. Routman, Jean-Claude M. Rwigema, Kathryn M. Van Abel, Linda X. Yin, Olivia M. Muller, Satomi Shiraishi
Format: Article
Language:English
Published: MDPI AG 2024-01-01
Series:Cancers
Subjects:
radiotherapy
head and neck cancer
oral cavity
organ at risk
adverse events
Online Access:https://www.mdpi.com/2072-6694/16/2/349

Internet

https://www.mdpi.com/2072-6694/16/2/349

Similar Items